Determine the Effect of MDV3100 on the Androgen Signaling Pathway in Correlation With the Anti-tumor Effects of MDV3100 to Identify Potential Predictors of Response or Resistance to Therapy
This study is ongoing, but not recruiting participants.
Study NCT01091103
Information provided by Medivation, Inc.
First Received on March 19, 2010.
Last Updated on August 27, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
